Thats awesome
Each has its own proposed mechanism, drawn almost entirely from cell-culture and animal models none is established in humans
Safety and Tolerability of GLP-1RAs for the Treatment of Obesity Since GLP-1RA therapy is used for the treatment of type 2 diabetes, there may be concerns about whether using an antidiabetic medication to treat obesity will increase the risk of hypoglycemia in people with obesity but without diabetes
Epithalon has been shown to enhance thymus gland function , improve immune cell activity, and promote immune surveillance against infections and abnormal cells
Pietropaoli, P., Caporelli, S., De Pace, F., Donati, A., Adrario, E., Luzi, A., Munch, C., Giovannini, C., and Frezzotti, A
The association between GLP-1 receptor agonists and diabetic retinopathy progression gained significant attention following the SUSTAIN-6 trial, published in 2016